RelA/MicroRNA-30a/NLRP3 signal axis is involved in rheumatoid arthritis via regulating NLRP3 inflammasome in

Qiudong Yang1,2,3,4, Wenhua Zhao1,3,4, Yuyi Chen2,3,4

  • 1Department of Basic Science of Stomatology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.

Cell Death & Disease
|November 9, 2021
PubMed

Insights

The RelA/miR-30a/NLRP3 signaling axis regulates the NLRP3 inflammasome in rheumatoid arthritis (RA) macrophages. Targeting this axis with miR-30a can reduce joint inflammation and bone damage in RA.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • The NLRP3 inflammasome is implicated in rheumatoid arthritis (RA) pathogenesis.
  • Post-transcriptional regulation of NLRP3 by microRNAs (miRNAs) in synovial macrophages remains poorly understood.

Purpose of the Study:

  • To investigate the role of miRNA-mediated post-transcriptional regulation of the NLRP3 inflammasome in RA.
  • To elucidate the mechanisms underlying RA pathogenesis involving the RelA/miR-30a/NLRP3 signaling axis.

Main Methods:

  • Utilized NLRP3-deficient (NLRP3KO) and TNFα-transgenic (TNFTG) mice (NLRP3KO/TNFTG) to study joint phenotypes.
  • Analyzed synovial macrophage markers (F4/80+, Caspase-1+, IL-1β+) and bone parameters (osteoblasts, osteoclasts).
  • Investigated the regulatory relationship between RelA, miR-30a, and NLRP3 in bone marrow-derived macrophages (BMDMs) and therapeutic potential of AAV-miR-30a in vivo.

Main Results:

  • TNFTG mice exhibited increased joint inflammation and bone erosion compared to wild-type (WT) mice.
  • NLRP3 knockout ameliorated joint inflammation and bone damage in TNFTG mice.
  • RelA positively regulated NLRP3 but negatively regulated miR-30a; miR-30a directly targeted NLRP3, forming a feedforward loop. Intra-articular AAV-miR-30a injection reduced RA phenotypes in TNFTG mice.

Conclusions:

  • The RelA/miR-30a/NLRP3 signaling axis is a key regulator of the NLRP3 inflammasome in RA pathogenesis.
  • Targeting this axis, specifically with miR-30a, demonstrates therapeutic potential for reducing joint inflammation and bone damage in RA.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K